GloBio Pharma, established in 2026 and based in Delhi, Delhi, India, operates as a Trader, Supplier, and Exporter of pharmaceutical products. Our company offers a growing portfolio comprising specialized injections, tablets, and other pharmaceutical formulations. Key products include Avastin Bevacizumab 100mg, Cisten 50 Cisplatin Injection, 120 Mg Denosumab Injection, Pertuzumab Injection, 100 Mg Golimumab Injection, 30 Mg Afatinib Tablets, and much more. We focus on serving pharmaceutical distributors, healthcare businesses, institutional buyers, and international customers. With an emphasis on professional coordination, customer responsiveness, efficient order handling, and dependable sourcing, our company aims to establish lasting business relationships and expand its presence in domestic and global pharmaceutical markets.
Key Facts of GloBio Pharma :
|
Nature of Business
|
Trader, Supplier and Exporter
|
|
Location
|
Delhi, Delhi, India
|
|
Year of Establishment
|
2026
|
|
No. of Employees
|
04
|
|
GST No.
|
07OHDPS4473M1ZE
|
|
Import/Export Code
|
OHDPS4473M
|
|
Export Percentage
|
30%
|
|
Mode of Payment
|
Online Payments (IMPS/RTGS/NEFT), Cheque/DD and Cash
|
|
Shipment Mode
|
Road Transport
|
|
| |
|
|
We deal only in bulk orders.